Betaxolol-Solopharm
Ophthalmology
Indications for use
Reduction of increased intraocular pressure in patients with ophthalmic hypertension and primary open-angle glaucoma as a monotherapy or in combination with other drugs.
Therapeutic class:
Antiglaucoma agent – beta-blocker
INN
Betaxolol
Market authorization in the following countries
Uzbekistan